DK505787A - Catecholderivater samt forebyggende og terapeutisk praeparat omfattende samme mod regressive sygdomme i centralnervesystemet - Google Patents

Catecholderivater samt forebyggende og terapeutisk praeparat omfattende samme mod regressive sygdomme i centralnervesystemet

Info

Publication number
DK505787A
DK505787A DK505787A DK505787A DK505787A DK 505787 A DK505787 A DK 505787A DK 505787 A DK505787 A DK 505787A DK 505787 A DK505787 A DK 505787A DK 505787 A DK505787 A DK 505787A
Authority
DK
Denmark
Prior art keywords
catechold
preventive
comprehensive
derivatives
nervous system
Prior art date
Application number
DK505787A
Other languages
Danish (da)
English (en)
Other versions
DK505787D0 (da
Inventor
Shigenobu Nakayama
Fumiaki Ikeda
Original Assignee
Mitsui Toatsu Chemicals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP61226135A external-priority patent/JPS6383020A/ja
Priority claimed from JP61303761A external-priority patent/JPS63156751A/ja
Priority claimed from JP62035697A external-priority patent/JPS63203678A/ja
Priority claimed from JP62128444A external-priority patent/JPS63295571A/ja
Application filed by Mitsui Toatsu Chemicals filed Critical Mitsui Toatsu Chemicals
Publication of DK505787D0 publication Critical patent/DK505787D0/da
Publication of DK505787A publication Critical patent/DK505787A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK505787A 1986-09-26 1987-09-25 Catecholderivater samt forebyggende og terapeutisk praeparat omfattende samme mod regressive sygdomme i centralnervesystemet DK505787A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP61226135A JPS6383020A (ja) 1986-09-26 1986-09-26 中枢性神経退行性疾患の進行防止および治療剤
JP61303761A JPS63156751A (ja) 1986-12-22 1986-12-22 カテコール誘導体の製造方法
JP62035697A JPS63203678A (ja) 1987-02-20 1987-02-20 新規なカテコール誘導体
JP62128444A JPS63295571A (ja) 1987-05-27 1987-05-27 カテコ−ル誘導体

Publications (2)

Publication Number Publication Date
DK505787D0 DK505787D0 (da) 1987-09-25
DK505787A true DK505787A (da) 1988-03-27

Family

ID=27460132

Family Applications (1)

Application Number Title Priority Date Filing Date
DK505787A DK505787A (da) 1986-09-26 1987-09-25 Catecholderivater samt forebyggende og terapeutisk praeparat omfattende samme mod regressive sygdomme i centralnervesystemet

Country Status (9)

Country Link
US (2) US4985458A (fr)
EP (1) EP0261977B1 (fr)
KR (1) KR900001511B1 (fr)
AU (1) AU603137B2 (fr)
DE (1) DE3777050D1 (fr)
DK (1) DK505787A (fr)
FI (1) FI874163A (fr)
NO (1) NO874032L (fr)
NZ (1) NZ221933A (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ228329A (en) * 1988-03-18 1991-12-23 Mitsui Toatsu Chemicals Catechol derivatives and pharmaceutical compositions thereof
US5232923A (en) * 1988-03-18 1993-08-03 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives and pharmaceutical preparations containing same
DD299424A5 (de) * 1989-05-23 1992-04-16 Sankyo Company Limited,Jp Phenolderivate zur foerderung des menschlichen nervenwachstumsfaktors
US5290793A (en) * 1989-09-12 1994-03-01 Mitsui Toatsu Chemicals, Incorporated Dihydrocaffeic acid derivatives and pharmaceutical preparation containing same
JPH0660141B2 (ja) * 1989-09-12 1994-08-10 三井東圧化学株式会社 ジヒドロカフェイン酸誘導体およびそれを有効成分として含有する治療剤
US5677288A (en) * 1991-05-15 1997-10-14 Cypros Pharmaceutical Corporation Use of aminoglycosides to protect against excitotoxic neuron damage
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases
US6242468B1 (en) 1997-02-27 2001-06-05 Jia-He Li Carbamate and urea compositions and neurotrophic uses
AU2474399A (en) 1998-01-26 1999-08-09 Mitokor Mitochondria protecting agents for treating mitochondria associated diseases
US5950896A (en) * 1998-02-09 1999-09-14 Theodore; Dean Anthony Multi-purpose thoracic sac
CN100346776C (zh) 2000-01-27 2007-11-07 宝生物工程株式会社 治疗剂
JP2001233835A (ja) * 2000-02-28 2001-08-28 Nagase & Co Ltd カルノジン酸誘導体およびそれを用いた神経成長因子合成促進剤
JP2005305107A (ja) * 2004-03-25 2005-11-04 Sei Matsuoka 価値的情報値の測定装置およびこれを使用した測定方法
FR2869033B1 (fr) * 2004-04-20 2006-06-02 Rhodia Chimie Sa Procede de preparation de methylenedioxybenzene
KR20110033304A (ko) * 2008-07-23 2011-03-30 메사추세츠 인스티튜트 오브 테크놀로지 Ｄｎａ 손상에 대해 보호하고 신경세포 생존을 증가시키는 히스톤 디아세틸라제 1 (ｈｄａｃ1)의 활성화
US9290473B2 (en) 2009-01-12 2016-03-22 Coucil Of Scientific & Industrial Research Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO)
RS58438B1 (sr) 2011-07-22 2019-04-30 Massachusetts Inst Technology Aktivatori klase i histonskih deacetilaza (hdacs) i njihova primena
US10253051B2 (en) 2015-03-16 2019-04-09 Lockheed Martin Energy, Llc Preparation of titanium catecholate complexes in aqueous solution using titanium tetrachloride or titanium oxychloride
US10644342B2 (en) 2016-03-03 2020-05-05 Lockheed Martin Energy, Llc Coordination complexes containing monosulfonated catecholate ligands and methods for producing the same
US10316047B2 (en) 2016-03-03 2019-06-11 Lockheed Martin Energy, Llc Processes for forming coordination complexes containing monosulfonated catecholate ligands
US9938308B2 (en) 2016-04-07 2018-04-10 Lockheed Martin Energy, Llc Coordination compounds having redox non-innocent ligands and flow batteries containing the same
US10343964B2 (en) 2016-07-26 2019-07-09 Lockheed Martin Energy, Llc Processes for forming titanium catechol complexes
US10377687B2 (en) * 2016-07-26 2019-08-13 Lockheed Martin Energy, Llc Processes for forming titanium catechol complexes
US10930937B2 (en) 2016-11-23 2021-02-23 Lockheed Martin Energy, Llc Flow batteries incorporating active materials containing doubly bridged aromatic groups
US10497958B2 (en) 2016-12-14 2019-12-03 Lockheed Martin Energy, Llc Coordinatively unsaturated titanium catecholate complexes and processes associated therewith

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE916208C (de) * 1951-06-05 1954-08-05 Pohl G Verfahren zur Herstellung einer Loesung von Hexylresorcin, insbesondere fuer Arzneimittelzwecke
FR7131M (fr) * 1968-01-31 1969-07-21
JPS4742760Y1 (fr) * 1969-02-19 1972-12-25
US3631227A (en) * 1970-02-27 1971-12-28 Texaco Inc Halocyclohexanone conversion to catechol diacetate
CA1004231A (en) * 1971-10-18 1977-01-25 Mahmoud S. Kablaoui Halocyclohexanone conversion to catechol diacetate
DE2155985A1 (de) * 1971-11-11 1973-05-17 Texaco Development Corp Verfahren zur herstellung von ggf. alkyliertem mono- oder diacetoxybenzol
IT1054578B (it) * 1976-01-30 1981-11-30 Brichima Spa Processo per la preparazione di composti metilendiossiaro matici
US4608391A (en) * 1977-07-05 1986-08-26 Cornell Research Foundation Inc. Catecholamine derivatives, a process for their preparation and pharmaceutical compositions thereof
DE2816190A1 (de) * 1978-04-14 1979-10-25 Bayer Ag Neue benzodioxolderivate
US4241097A (en) * 1979-09-13 1980-12-23 International Flavors & Fragrances Inc. Use of benzodionones in augmenting or enhancing the aroma and taste of a foodstuff
CA1175058A (fr) * 1980-04-07 1984-09-25 James E. Lyons Preparation selective de diacetate de phenylene
DE3332955A1 (de) * 1983-09-13 1985-03-28 Merck Patent Gmbh, 6100 Darmstadt Carbocyclische sechsringverbindungen
US4559328A (en) * 1984-06-21 1985-12-17 Warner-Lambert Company Non-steroidal anti-inflammatory compounds to treat inflammation
DE3431222A1 (de) * 1984-08-24 1986-03-06 Bayer Ag, 5090 Leverkusen Neue benzokondensierte, fluorierte, heterocyclische verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung
TR22733A (tr) * 1984-12-14 1988-05-24 Clorox Co Fenilen mono-ve diester perasit iptidai maddeler
US4761491A (en) * 1984-12-24 1988-08-02 The Dow Chemical Company Preparation of 2-substituted-1,3-dioxacycloalkanes from diols and diunsaturated ethers
JPS61197541A (ja) * 1985-02-26 1986-09-01 Sanyo Kokusaku Pulp Co Ltd 新規なアクリレ−ト化合物およびその製造法
US4820366A (en) * 1987-03-06 1989-04-11 Phillips Petroleum Company Apparatus and method for pultruding reinforced plastic articles
US4803290A (en) * 1987-05-29 1989-02-07 Pcri, Inc. Nonanol/nonene antimicrobial compositions
JPH02249945A (ja) * 1989-03-24 1990-10-05 Hitachi Ltd 折り曲げ強度検査装置

Also Published As

Publication number Publication date
EP0261977B1 (fr) 1992-03-04
AU7895687A (en) 1988-03-31
DE3777050D1 (de) 1992-04-09
EP0261977A2 (fr) 1988-03-30
US5102906A (en) 1992-04-07
KR900001511B1 (ko) 1990-03-12
NZ221933A (en) 1989-09-27
NO874032D0 (no) 1987-09-25
KR880003622A (ko) 1988-05-28
EP0261977A3 (en) 1989-04-05
US4985458A (en) 1991-01-15
FI874163A0 (fi) 1987-09-23
AU603137B2 (en) 1990-11-08
FI874163A (fi) 1988-03-27
NO874032L (no) 1988-03-28
DK505787D0 (da) 1987-09-25

Similar Documents

Publication Publication Date Title
DK505787D0 (da) Catecholderivater samt forebyggende og terapeutisk praeparat omfattende samme mod regressive sygdomme i centralnervesystemet
GB2231265B (en) Therapeutic use of serotonin-antagonists
DK476089A (da) Terapeutisk aktive forbindelser og deres fremstilling
EP0234854A3 (en) Preparations for stimulation of tear secrtetion with phosphodiesterase inhibitors and cyclic nucleotideanalogues
IT8867534A0 (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
NO864130D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karboksamid-derivater.
IT1183181B (it) Derivati del 3-metil-imidazo(4,5-c)pirazolo con attivita' terapeutica e procedimento per la loropreparazione
DK397388D0 (da) Derivater af n-aminobutyl-n-phenylarylamider til terapeutisk anvendelse samt fremgangsmaade til fremstilling af saadanne derivater
NO864131D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive indol-og indazol-ketosulfon-derivater.
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
IT1203738B (it) Bilirubin-cssidasi termostabile e procedimento per produrla
NO171242C (no) Fremgangsmaate for fremstilling av hudpleiepreparater med keratolytisk og antiinflammatorisk virkning
DK20587A (da) Kosmetiske midler med hudberoligende og hudregenererende virkning og fremgangsmaade til deres fremstilling
NO873835L (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbocykliske pyridiner.
GB8522962D0 (en) Treatment of viral diseases in plants
NO168473C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner.
DK681288D0 (da) Aenootropt terapeutisk laegemiddelae
RO92461A2 (fr) Solution medicamenteuse pour la prevention et la therapie des affections parodontales
DK388387A (da) Modificerede virus-glycoproteiner og deres anvendelse til diagnostiske og terapeutiske formaal
IT8450806V0 (it) Sacchetto terapeutico per stimolazione meccanica ed autostimolazione
SE8702825D0 (sv) New synergistic preparations and a new method of alleviation of pain
NO923942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive metylendioksyfenantren-derivater
GB8514096D0 (en) Treatment of skin diseases
NO172984C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater samt mellomprodukt for anvendelse i fremgangsmaaten
ZA875652B (en) Therapeutic use of serotonin-antagonists

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment